BCL2 and cancer: Surprisingly, although venetoclax is a BCL2 inhibitor, an anti-apoptotic protein that is pathologically overexpressed and crucial to the survival of certain cancer cells, Caco-2 cell proliferation was not affected by treatment with this drug.